Identification of Functional Differences in Metabolic Networks Using Comparative Genomics and Constraint-Based Models

Genome-scale network reconstructions are useful tools for understanding cellular metabolism, and comparisons of such reconstructions can provide insight into metabolic differences between organisms. Recent efforts toward comparing genome-scale models have focused primarily on aligning metabolic networks at the reaction level and then looking at differences and similarities in reaction and gene content. However, these reaction comparison approaches are time-consuming and do not identify the effect network differences have on the functional states of the network. We have developed a bilevel mixed-integer programming approach, CONGA, to identify functional differences between metabolic networks by comparing network reconstructions aligned at the gene level. We first identify orthologous genes across two reconstructions and then use CONGA to identify conditions under which differences in gene content give rise to differences in metabolic capabilities. By seeking genes whose deletion in one or both models disproportionately changes flux through a selected reaction (e.g., growth or by-product secretion) in one model over another, we are able to identify structural metabolic network differences enabling unique metabolic capabilities. Using CONGA, we explore functional differences between two metabolic reconstructions of Escherichia coli and identify a set of reactions responsible for chemical production differences between the two models. We also use this approach to aid in the development of a genome-scale model of Synechococcus sp. PCC 7002. Finally, we propose potential antimicrobial targets in Mycobacterium tuberculosis and Staphylococcus aureus based on differences in their metabolic capabilities. Through these examples, we demonstrate that a gene-centric approach to comparing metabolic networks allows for a rapid comparison of metabolic models at a functional level. Using CONGA, we can identify differences in reaction and gene content which give rise to different functional predictions. Because CONGA provides a general framework, it can be applied to find functional differences across models and biological systems beyond those presented here.

[1]  R. Mahadevan,et al.  The effects of alternate optimal solutions in constraint-based genome-scale metabolic models. , 2003, Metabolic engineering.

[2]  Monica L. Mo,et al.  Global reconstruction of the human metabolic network based on genomic and bibliomic data , 2007, Proceedings of the National Academy of Sciences.

[3]  Vinay Satish Kumar,et al.  Metabolic reconstruction of the archaeon methanogen Methanosarcina Acetivorans , 2011, BMC Systems Biology.

[4]  Jonathan A. Kelner,et al.  Large-scale identification of genetic design strategies using local search , 2009, Molecular systems biology.

[5]  B. Palsson,et al.  Systems approach to refining genome annotation , 2006, Proceedings of the National Academy of Sciences.

[6]  Adam M. Feist,et al.  Model-driven evaluation of the production potential for growth-coupled products of Escherichia coli. , 2010, Metabolic engineering.

[7]  Peter D. Karp,et al.  The MetaCyc Database of metabolic pathways and enzymes and the BioCyc collection of Pathway/Genome Databases , 2007, Nucleic Acids Res..

[8]  B. Palsson,et al.  An expanded genome-scale model of Escherichia coli K-12 (iJR904 GSM/GPR) , 2003, Genome Biology.

[9]  N. Murata,et al.  Acyl-lipid desaturases and their importance in the tolerance and acclimatization to cold of cyanobacteria. , 1995, The Biochemical journal.

[10]  Bernhard O. Palsson,et al.  BiGG: a Biochemical Genetic and Genomic knowledgebase of large scale metabolic reconstructions , 2010, BMC Bioinformatics.

[11]  Peter D. Karp,et al.  Pathway Tools version 13.0: integrated software for pathway/genome informatics and systems biology , 2015, Briefings Bioinform..

[12]  Adam M. Feist,et al.  Reconstruction of biochemical networks in microorganisms , 2009, Nature Reviews Microbiology.

[13]  K. Reynolds,et al.  Purification, Characterization, and Identification of Novel Inhibitors of the β-Ketoacyl-Acyl Carrier Protein Synthase III (FabH) from Staphylococcus aureus , 2002, Antimicrobial Agents and Chemotherapy.

[14]  P. Fu,et al.  Genome‐scale modeling of Synechocystis sp. PCC 6803 and prediction of pathway insertion , 2009 .

[15]  A. Melis,et al.  Engineering a platform for photosynthetic isoprene production in cyanobacteria, using Synechocystis as the model organism. , 2010, Metabolic engineering.

[16]  B. Palsson,et al.  Genome-scale models of microbial cells: evaluating the consequences of constraints , 2004, Nature Reviews Microbiology.

[17]  Naryttza N. Diaz,et al.  The Subsystems Approach to Genome Annotation and its Use in the Project to Annotate 1000 Genomes , 2005, Nucleic acids research.

[18]  Tomer Shlomi,et al.  Predicting metabolic engineering knockout strategies for chemical production: accounting for competing pathways , 2010, Bioinform..

[19]  R. Hancock Mechanisms of action of newer antibiotics for Gram-positive pathogens. , 2005, The Lancet. Infectious diseases.

[20]  Xuefeng Lu,et al.  Photosynthesis driven conversion of carbon dioxide to fatty alcohols and hydrocarbons in cyanobacteria. , 2011, Metabolic engineering.

[21]  Kathleen Marchal,et al.  A community effort towards a knowledge-base and mathematical model of the human pathogen Salmonella Typhimurium LT2 , 2011, BMC Systems Biology.

[22]  Jason A. Papin,et al.  Reconciliation of Genome-Scale Metabolic Reconstructions for Comparative Systems Analysis , 2011, PLoS Comput. Biol..

[23]  Michael C. Ferris,et al.  Linear programming with MATLAB , 2007, MPS-SIAM series on optimization.

[24]  A. Burgard,et al.  Minimal Reaction Sets for Escherichia coli Metabolism under Different Growth Requirements and Uptake Environments , 2001, Biotechnology progress.

[25]  Jens Nielsen,et al.  Evolutionary programming as a platform for in silico metabolic engineering , 2005, BMC Bioinformatics.

[26]  H. Neu,et al.  The Crisis in Antibiotic Resistance , 1992, Science.

[27]  Jeffrey D Orth,et al.  What is flux balance analysis? , 2010, Nature Biotechnology.

[28]  K. Gajiwala,et al.  Structure-based design, synthesis, and study of potent inhibitors of β-ketoacyl-acyl carrier protein synthase III as potential antimicrobial agents , 2005 .

[29]  John A Morgan,et al.  Flux Balance Analysis of Photoautotrophic Metabolism , 2005, Biotechnology progress.

[30]  Ying Zhang,et al.  Mode of action of pyrazinamide: disruption of Mycobacterium tuberculosis membrane transport and energetics by pyrazinoic acid. , 2003, The Journal of antimicrobial chemotherapy.

[31]  Bernhard O. Palsson,et al.  Investigating the metabolic capabilities of Mycobacterium tuberculosis H37Rv using the in silico strain iNJ661 and proposing alternative drug targets , 2007 .

[32]  E. Myers,et al.  Basic local alignment search tool. , 1990, Journal of molecular biology.

[33]  R. Skurray,et al.  Antimicrobial resistance of Staphylococcus aureus: genetic basis. , 1987, Microbiological reviews.

[34]  A. Burgard,et al.  Optknock: A bilevel programming framework for identifying gene knockout strategies for microbial strain optimization , 2003, Biotechnology and bioengineering.

[35]  C. Aldrich,et al.  Inhibition of siderophore biosynthesis in Mycobacterium tuberculosis with nucleoside bisubstrate analogues: structure-activity relationships of the nucleobase domain of 5'-O-[N-(salicyl)sulfamoyl]adenosine. , 2008, Journal of medicinal chemistry.

[36]  David L. Wheeler,et al.  GenBank , 2015, Nucleic Acids Res..

[37]  Priyanka Verma,et al.  Mechanistic and functional insights into fatty acid activation in Mycobacterium tuberculosis , 2009, Nature chemical biology.

[38]  William R. Jacobs,et al.  Pyrazinamide inhibits the eukaryotic-like fatty acid synthetase I (FASI) of Mycobacterium tuberculosis , 2000, Nature Medicine.

[39]  Kiran Raosaheb Patil,et al.  Reconstruction and analysis of genome-scale metabolic model of a photosynthetic bacterium , 2010, BMC Systems Biology.

[40]  D. Bumann Has nature already identified all useful antibacterial targets? , 2008, Current opinion in microbiology.

[41]  Jennifer L. Reed,et al.  OptORF: Optimal metabolic and regulatory perturbations for metabolic engineering of microbial strains , 2010, BMC Systems Biology.

[42]  B. Palsson,et al.  Genome-scale reconstruction of the metabolic network in Staphylococcus aureus N315: an initial draft to the two-dimensional annotation , 2005, BMC Microbiology.

[43]  Christoph Benning,et al.  BIOSYNTHESIS AND FUNCTION OF THE SULFOLIPID SULFOQUINOVOSYL DIACYLGLYCEROL. , 1998, Annual review of plant physiology and plant molecular biology.

[44]  James C Liao,et al.  Direct photosynthetic recycling of carbon dioxide to isobutyraldehyde , 2009, Nature Biotechnology.

[45]  G. Stephanopoulos,et al.  Identifying gene targets for the metabolic engineering of lycopene biosynthesis in Escherichia coli. , 2005, Metabolic engineering.

[46]  C. Stoeckert,et al.  OrthoMCL: identification of ortholog groups for eukaryotic genomes. , 2003, Genome research.

[47]  V. Hatzimanikatis,et al.  Manipulating redox and ATP balancing for improved production of succinate in E. coli. , 2011, Metabolic engineering.

[48]  J. Reed,et al.  Large-Scale Bi-Level Strain Design Approaches and Mixed-Integer Programming Solution Techniques , 2011, PloS one.

[49]  Rick L. Stevens,et al.  High-throughput generation, optimization and analysis of genome-scale metabolic models , 2010, Nature Biotechnology.

[50]  Costas D Maranas,et al.  OptStrain: a computational framework for redesign of microbial production systems. , 2004, Genome research.

[51]  Markus J. Herrgård,et al.  A consensus yeast metabolic network reconstruction obtained from a community approach to systems biology , 2008, Nature Biotechnology.

[52]  Jason A. Papin,et al.  Applications of genome-scale metabolic reconstructions , 2009, Molecular systems biology.

[53]  Markus J. Herrgård,et al.  Integrating high-throughput and computational data elucidates bacterial networks , 2004, Nature.

[54]  F. Blattner,et al.  In silico design and adaptive evolution of Escherichia coli for production of lactic acid. , 2005, Biotechnology and bioengineering.

[55]  William R Cluett,et al.  EMILiO: a fast algorithm for genome-scale strain design. , 2011, Metabolic engineering.

[56]  S. Lee,et al.  Metabolic Engineering of Escherichia coli for Enhanced Production of Succinic Acid, Based on Genome Comparison and In Silico Gene Knockout Simulation , 2005, Applied and Environmental Microbiology.

[57]  S. Lee,et al.  Integrative genome-scale metabolic analysis of Vibrio vulnificus for drug targeting and discovery , 2011, Molecular systems biology.

[58]  Jim K. Fredrickson,et al.  Constraint-Based Model of Shewanella oneidensis MR-1 Metabolism: A Tool for Data Analysis and Hypothesis Generation , 2010, PLoS Comput. Biol..

[59]  Xinyao Liu,et al.  Fatty acid production in genetically modified cyanobacteria , 2011, Proceedings of the National Academy of Sciences.

[60]  John D. C. Little,et al.  On model building , 1993 .

[61]  R. Lange,et al.  The targets of currently used antibacterial agents: lessons for drug discovery. , 2007, Current pharmaceutical design.

[62]  V. Stepanshina,et al.  [Molecular mechanisms of drug resistance of Mycobacterium tuberculosis]. , 1999, Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic].

[63]  Bernhard O. Palsson,et al.  Constraint-based analysis of metabolic capacity of Salmonella typhimurium during host-pathogen interaction , 2009, BMC Systems Biology.

[64]  C. Walsh,et al.  D-Alanyl-D-alanine ligases and the molecular mechanism of vancomycin resistance , 1992 .

[65]  Costas D. Maranas,et al.  OptForce: An Optimization Procedure for Identifying All Genetic Manipulations Leading to Targeted Overproductions , 2010, PLoS Comput. Biol..

[66]  中尾 光輝,et al.  KEGG(Kyoto Encyclopedia of Genes and Genomes)〔和文〕 (特集 ゲノム医学の現在と未来--基礎と臨床) -- (データベース) , 2000 .

[67]  A. Sauve,et al.  Characterization of nicotinamidases: steady state kinetic parameters, classwide inhibition by nicotinaldehydes, and catalytic mechanism. , 2010, Biochemistry.

[68]  W. Lockau,et al.  The Metabolic Network of Synechocystis sp. PCC 6803: Systemic Properties of Autotrophic Growth1[C][W] , 2010, Plant Physiology.

[69]  Jim K. Fredrickson,et al.  Genome-Scale Modeling of Light-Driven Reductant Partitioning and Carbon Fluxes in Diazotrophic Unicellular Cyanobacterium Cyanothece sp. ATCC 51142 , 2012, PLoS Comput. Biol..

[70]  Adam M. Feist,et al.  The growing scope of applications of genome-scale metabolic reconstructions using Escherichia coli , 2008, Nature Biotechnology.

[71]  L. Nielsen,et al.  The genome sequence of E. coli W (ATCC 9637): comparative genome analysis and an improved genome-scale reconstruction of E. coli , 2011, BMC Genomics.

[72]  C. Walsh Opinion — anti-infectives: Where will new antibiotics come from? , 2003, Nature Reviews Microbiology.

[73]  C. Maranas,et al.  An optimization framework for identifying reaction activation/inhibition or elimination candidates for overproduction in microbial systems. , 2006, Metabolic engineering.

[74]  Jun Sun,et al.  Genome-scale constraint-based modeling of Geobacter metallireducens , 2009, BMC Systems Biology.

[75]  H. P. Williams,et al.  Model Building in Mathematical Programming , 1979 .

[76]  Adam M. Feist,et al.  A genome-scale metabolic reconstruction for Escherichia coli K-12 MG1655 that accounts for 1260 ORFs and thermodynamic information , 2007, Molecular systems biology.

[77]  Jun Sun,et al.  Constraint-based modeling analysis of the metabolism of two Pelobacter species , 2010, BMC Systems Biology.

[78]  D. Bryant,et al.  Alteration of low-temperature susceptibility of the cyanobacterium Synechococcus sp. PCC 7002 by genetic manipulation of membrane lipid unsaturation , 1997, Archives of Microbiology.